Effectdossier · gearchiveerd kwartaal
ABUS
Arbutus Biopharma Corp · Healthcare · Biotechnology
16Gevolgde houders
0Δ houders
63.04MGehouden aandelen
$286.21MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +3.6% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +3 | 78.82M | $378.29M | +13 | −10 |
| Q1 2026 | 75 | -5 | 80.64M | $362.88M | +5 | −10 |
| Q4 2025 | 79 | -1 | 77.73M | $373.87M | — | −1 |
| Q3 2025 | 16 | 0 | 63.04M | $286.21M | +1 | −1 |
| Q2 2025 | 13 | +1 | 34.03M | $105.14M | +1 | — |
| Q1 2025 | 9 | 0 | 10.62M | $37.08M | — | — |
| Q4 2024 | 9 | 0 | 11.43M | $37.37M | — | — |
| Q3 2024 | 8 | +1 | 7.82M | $30.10M | +1 | — |
| Q2 2024 | 7 | — | 7.20M | $22.26M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 5.01M | +94.7% | $22.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (passief) | 4.10M | -8.1% | $18.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passief) | 3.67M | +0.8% | $16.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passief) | 3.67M | +0.8% | $16.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 2.17M | — | $9.87M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 2.17M | — | $9.87M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Millennium Management ✦ | 528.34K | +5.8% | $2.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 193.69K | +61.0% | $879,357 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 189.95K | +366.7% | $862,382 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | D. E. Shaw & Co. ✦ | 189.95K | +366.7% | $862,382 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 46 | Arrowstreet Capital ✦ | 159.12K | Nieuw | $722,396 | 0.0% | New | 1 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 89.46K | +10.8% | $406,165 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 48 | Fidelity (FMR) ✦ | 89.46K | +10.8% | $406,165 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 49 | T. Rowe Price ✦ | 83.01K | +8.5% | $377,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Arrowstreet Capital | $722,396 | 0.0% |
Verlaten
| Two Sigma Investments | $34,914 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 166 houders, 138.84M aandelen, $623.91M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API